SpectraCure
Research SpectraCure (SPEC.ST) on Bullrun: market cap SEK 13.61M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSPEC.ST
- ExchangeSSME
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 13.61M
- Financial periodQ1 2026
- RevenueSEK 0
- Net income-SEK 6.14M
- Free cash flow-SEK 9.33M
Valuation Snapshot
latest market cap is SEK 13.61M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 0 | -SEK 56.08M | -SEK 43.67M | n/a | -0.13 | SEK 13.53M | SEK 2.79M | SEK 93.55M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-06 | SEK 13.61M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About SpectraCure
SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SpectraCure's market cap?
SpectraCure's market capitalization is SEK 13.61M.
What does SpectraCure do?
SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.